CN100408698C - 用于确定大前庭水管综合症耳聋pds基因的引物 - Google Patents
用于确定大前庭水管综合症耳聋pds基因的引物 Download PDFInfo
- Publication number
- CN100408698C CN100408698C CNB2006100582826A CN200610058282A CN100408698C CN 100408698 C CN100408698 C CN 100408698C CN B2006100582826 A CNB2006100582826 A CN B2006100582826A CN 200610058282 A CN200610058282 A CN 200610058282A CN 100408698 C CN100408698 C CN 100408698C
- Authority
- CN
- China
- Prior art keywords
- ivs7
- primer
- site
- test kit
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 101150108119 PDS gene Proteins 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 31
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 26
- 206010011878 Deafness Diseases 0.000 title description 33
- 206010064571 Gene mutation Diseases 0.000 title description 2
- 238000000338 in vitro Methods 0.000 title 1
- 230000035772 mutation Effects 0.000 claims abstract description 22
- 210000002905 vestibular aqueduct Anatomy 0.000 claims abstract description 22
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 21
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 8
- 238000012360 testing method Methods 0.000 claims description 35
- 108091008146 restriction endonucleases Proteins 0.000 claims description 33
- 108020004414 DNA Proteins 0.000 claims description 25
- 210000004369 blood Anatomy 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 239000008280 blood Substances 0.000 claims description 13
- 238000013016 damping Methods 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 210000005259 peripheral blood Anatomy 0.000 claims description 7
- 239000011886 peripheral blood Substances 0.000 claims description 7
- 230000000869 mutational effect Effects 0.000 claims description 4
- 108700024394 Exon Proteins 0.000 claims description 2
- 238000003149 assay kit Methods 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000007017 scission Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 3
- 230000004544 DNA amplification Effects 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 description 35
- 108090000790 Enzymes Proteins 0.000 description 35
- 239000000523 sample Substances 0.000 description 33
- 101001094048 Homo sapiens Pendrin Proteins 0.000 description 19
- 102100035278 Pendrin Human genes 0.000 description 18
- 238000001514 detection method Methods 0.000 description 12
- 208000016354 hearing loss disease Diseases 0.000 description 11
- 230000013707 sensory perception of sound Effects 0.000 description 10
- 238000013461 design Methods 0.000 description 8
- 230000003321 amplification Effects 0.000 description 7
- 231100000895 deafness Toxicity 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000013642 negative control Substances 0.000 description 5
- 238000012882 sequential analysis Methods 0.000 description 5
- 238000007400 DNA extraction Methods 0.000 description 4
- 108010042407 Endonucleases Proteins 0.000 description 4
- 102000004533 Endonucleases Human genes 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 210000003582 temporal bone Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 231100000888 hearing loss Toxicity 0.000 description 3
- 230000010370 hearing loss Effects 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- 206010013886 Dysaesthesia Diseases 0.000 description 2
- 208000004843 Pendred Syndrome Diseases 0.000 description 2
- 102000011384 Pendrin Human genes 0.000 description 2
- 108050001616 Pendrin Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- -1 5 μ l Substances 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000370738 Chlorion Species 0.000 description 1
- 206010022773 Intracranial pressure increased Diseases 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102000037054 SLC-Transporter Human genes 0.000 description 1
- 108091006207 SLC-Transporter Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000021024 autosomal recessive inheritance Diseases 0.000 description 1
- 201000011345 autosomal recessive nonsyndromic deafness 4 Diseases 0.000 description 1
- 208000032347 autosomal recessive nonsyndromic hearing loss 4 Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000009941 intracranial hypertension Diseases 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 201000006790 nonsyndromic deafness Diseases 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 208000027765 speech disease Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/138—Amplified fragment length polymorphism [AFLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
突变类型 | IVS 7-2A→G试剂盒法 | 序列分析 | 颞骨CT |
纯合 | 5例 | 5例 | 5例前庭水管扩大 |
杂合 | 4例 | 4例 | 4例前庭水管扩大 |
阴性 | 11例 | 11例 | 11例均无异常 |
Claims (7)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100582826A CN100408698C (zh) | 2006-02-28 | 2006-02-28 | 用于确定大前庭水管综合症耳聋pds基因的引物 |
KR20087014115A KR20080109715A (ko) | 2006-02-28 | 2007-01-24 | 체외에서 전정 도수관 확장성 청각 장애와 관련있는 pds유전자 돌연변이를 검출하는 프라이머의 제조방법 및 용도 |
JP2008556634A JP2009528036A (ja) | 2006-02-28 | 2007-01-24 | 前庭水管拡大症候群性難聴に関連するpds遺伝子の突然変異を体外で特定するためのプライマーの製造方法及びその使用 |
US12/095,317 US20090311676A1 (en) | 2006-02-28 | 2007-01-24 | Method for preparing primer used for determining the mutation in PDS gene related to large vestibular aqueduct syndrome in vitro and the use of the primer |
PCT/CN2007/000260 WO2007098671A1 (en) | 2006-02-28 | 2007-01-24 | A method for preparing the primers for in vitro identifying mutations within larged vestibular aqueduct syndromic hearing loss pds gene and the use thereof |
EP07710830A EP1990426A4 (en) | 2006-02-28 | 2007-01-24 | METHOD OF PREPARING PRIMERS FOR THE IN VITRO IDENTIFICATION OF MUTATIONS IN THE PDS GENE OF SYNDROMIC SUREDANCE WITH ENHANCED VESTIBULAR AQUEDUC AND USE THEREOF |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100582826A CN100408698C (zh) | 2006-02-28 | 2006-02-28 | 用于确定大前庭水管综合症耳聋pds基因的引物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1850992A CN1850992A (zh) | 2006-10-25 |
CN100408698C true CN100408698C (zh) | 2008-08-06 |
Family
ID=37132494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100582826A Expired - Fee Related CN100408698C (zh) | 2006-02-28 | 2006-02-28 | 用于确定大前庭水管综合症耳聋pds基因的引物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090311676A1 (zh) |
EP (1) | EP1990426A4 (zh) |
JP (1) | JP2009528036A (zh) |
KR (1) | KR20080109715A (zh) |
CN (1) | CN100408698C (zh) |
WO (1) | WO2007098671A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104711367B (zh) * | 2015-04-03 | 2016-06-22 | 济南英盛生物技术有限公司 | 一种迟发性耳聋基因多通道荧光pcr检测试剂盒 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050112598A1 (en) * | 2003-02-24 | 2005-05-26 | Greinwald John H.Jr. | Microarray-based diagnosis of pediatric hearing impairment-construction of a deafness gene chip |
CN1699595A (zh) * | 2004-05-21 | 2005-11-23 | 北京诺赛基因组研究中心有限公司 | 检测与人类遗传性耳聋相关的wfs1基因突变的方法 |
CN1730655A (zh) * | 2004-12-21 | 2006-02-08 | 中国人民解放军总医院 | 与人类遗传性耳聋相关的gjb6突变基因及其在诊断遗传性耳聋中的应用 |
CN1733937A (zh) * | 2005-04-28 | 2006-02-15 | 中国人民解放军总医院 | 耳聋相关基因突变及其检测方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6372424B1 (en) * | 1995-08-30 | 2002-04-16 | Third Wave Technologies, Inc | Rapid detection and identification of pathogens |
US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
-
2006
- 2006-02-28 CN CNB2006100582826A patent/CN100408698C/zh not_active Expired - Fee Related
-
2007
- 2007-01-24 WO PCT/CN2007/000260 patent/WO2007098671A1/zh active Application Filing
- 2007-01-24 KR KR20087014115A patent/KR20080109715A/ko not_active Application Discontinuation
- 2007-01-24 US US12/095,317 patent/US20090311676A1/en not_active Abandoned
- 2007-01-24 JP JP2008556634A patent/JP2009528036A/ja active Pending
- 2007-01-24 EP EP07710830A patent/EP1990426A4/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050112598A1 (en) * | 2003-02-24 | 2005-05-26 | Greinwald John H.Jr. | Microarray-based diagnosis of pediatric hearing impairment-construction of a deafness gene chip |
CN1699595A (zh) * | 2004-05-21 | 2005-11-23 | 北京诺赛基因组研究中心有限公司 | 检测与人类遗传性耳聋相关的wfs1基因突变的方法 |
CN1730655A (zh) * | 2004-12-21 | 2006-02-08 | 中国人民解放军总医院 | 与人类遗传性耳聋相关的gjb6突变基因及其在诊断遗传性耳聋中的应用 |
CN1733937A (zh) * | 2005-04-28 | 2006-02-15 | 中国人民解放军总医院 | 耳聋相关基因突变及其检测方法 |
Non-Patent Citations (10)
Title |
---|
Molecular analysis of the PDS gene in Pendred syndrome(sensorineural hearing loss and goitre). Beth Coyle,William Reardon,Jo-Anne Herbrick et al.Human Molecular Genetics,Vol.7 No.7. 1998 |
Molecular analysis of the PDS gene in Pendred syndrome(sensorineural hearing loss and goitre). Beth Coyle,William Reardon,Jo-Anne Herbrick et al.Human Molecular Genetics,Vol.7 No.7. 1998 * |
PDS基因检测--诊断大前庭水管综合征的新方法. 戴朴,黄德亮,王嘉陵等.中华耳科学杂志,第3卷第4期. 2005 |
PDS基因检测--诊断大前庭水管综合征的新方法. 戴朴,黄德亮,王嘉陵等.中华耳科学杂志,第3卷第4期. 2005 * |
Pendred Syndrome and DFNB4-Mutation Screening ofSLC26A4 by Denaturing High-Performance LiquidChromatography and the Identification of ElevenNovel Mutations. Sai Prasad,Karen A. Ko¨ lln,Robert A. Cucci et al.American Journal of Medical Genetics,Vol.124A . 2004 |
Pendred Syndrome and DFNB4-Mutation Screening ofSLC26A4 by Denaturing High-Performance LiquidChromatography and the Identification of ElevenNovel Mutations. Sai Prasad,Karen A. Ko¨ lln,Robert A. Cucci et al.American Journal of Medical Genetics,Vol.124A . 2004 * |
学语前性耳聋疾病相关基因的产前诊断. 胡浩,邬玲仟,梁德生等.中华妇产科杂志,第40卷第9期. 2005 |
学语前性耳聋疾病相关基因的产前诊断. 胡浩,邬玲仟,梁德生等.中华妇产科杂志,第40卷第9期. 2005 * |
线粒体DNA1555位点和GJB2基因及SLC26A4基因的诊断方法及临床应用. 戴朴,于飞,康东洋等.中华耳鼻咽喉头颈外科杂志,第40卷第10期. 2005 |
线粒体DNA1555位点和GJB2基因及SLC26A4基因的诊断方法及临床应用. 戴朴,于飞,康东洋等.中华耳鼻咽喉头颈外科杂志,第40卷第10期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
KR20080109715A (ko) | 2008-12-17 |
EP1990426A1 (en) | 2008-11-12 |
EP1990426A4 (en) | 2009-11-18 |
JP2009528036A (ja) | 2009-08-06 |
WO2007098671A1 (en) | 2007-09-07 |
CN1850992A (zh) | 2006-10-25 |
WO2007098671A8 (zh) | 2009-11-05 |
US20090311676A1 (en) | 2009-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104928373B (zh) | 一种帕金森病的基因诊断试剂盒 | |
CN103898211B (zh) | 肌萎缩侧索硬化症的基因诊断试剂盒 | |
CN104561016A (zh) | 先天性白内障pitx3基因新突变 | |
CN105200040A (zh) | 一种用于在单细胞水平上同时检测多种耳聋基因的试剂盒 | |
CN104450727A (zh) | X-连锁低磷酸盐血症性佝偻病的致病基因及其编码蛋白质和应用 | |
Whaley et al. | Mapping of D4S98/S114/S113 confines the Huntington's defect to a reduced physical region at the telomere of chromosome 4 | |
CN101363054A (zh) | 体外检测遗传性耳聋相关缝隙连接蛋白26基因gjb2突变的方法及检测用试剂盒 | |
CN103757028B (zh) | Osbpl2突变型基因、其鉴定方法和检测试剂盒 | |
CN109913482A (zh) | Pik3ca-i874r突变基因及其在乳腺癌辅助诊断中的应用 | |
CN104073499B (zh) | Tmc1基因突变体及其应用 | |
CN100408698C (zh) | 用于确定大前庭水管综合症耳聋pds基因的引物 | |
CN104450728B (zh) | Or2w3基因突变体及其应用 | |
Gallione et al. | Genetic genealogy uncovers a founder deletion mutation in the cerebral cavernous malformations 2 gene | |
CN104099338B (zh) | Myo15a基因突变体及其应用 | |
CN113584207B (zh) | 芝麻育性分子标记、引物、试剂盒、应用、高木酚素芝麻新品种选育方法 | |
CN103045722B (zh) | 结晶样先天性白内障致病基因crygd检测试剂盒 | |
CN105838720A (zh) | Ptprq基因突变体及其应用 | |
Ostrovsky et al. | Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel | |
CN104789572B (zh) | Gprasp2突变型基因、其鉴定方法和检测试剂盒 | |
CN107099616A (zh) | 检测ret基因突变的引物组及其应用和应用其的产品以及检测ret基因突变的方法 | |
Pshennikova et al. | Analysis of GJB6 (Сx30) and GJB3 (Сx31) genes in deaf patients with monoallelic mutations in GJB2 (Сx26) gene in the Sakha Republic (Yakutia) | |
CN101525620B (zh) | Coppock白内障致病基因及其检测方法 | |
CN106148528B (zh) | 一种遗传性Usher综合征的致病突变及其检测试剂 | |
CN108998527A (zh) | 一种鼻咽癌发病风险相关的骨桥蛋白功能性snp及应用 | |
CN107603985B (zh) | 秃顶男性生精障碍致病基因jag1及其检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: DONGGUAN CITY AOMAIER GENE TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: JIN ZHENGCE Effective date: 20090327 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090327 Address after: Guangdong province Dongguan City Songshan Lake Science and Technology Industrial Park Building 2 floor 13 Keyuan pine Room 201 Patentee after: Dongguan Aomaier Genetic Technology Co., Ltd. Address before: No. 46 east east street, Beijing, Dongcheng District Patentee before: Jin Zhengce |
|
C56 | Change in the name or address of the patentee |
Owner name: QINGYUAN AOMAIER GENE TECHNOLOGY CO., LTD. Free format text: FORMER NAME: DONGGUAN AOMAIER GENETIC TECHNOLOGY CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 511500 Guangdong Qingcheng District Qingyuan City, North River two Lu Sheng Ping Street Yingbin Hotel Nanyuan Patentee after: Qingyuan Australia Gene Technology Co., Ltd. Address before: 523808 Guangdong province Dongguan City Songshan Lake Science and Technology Industrial Park Building 2 floor 13 Keyuan pine Room 201 Patentee before: Dongguan Aomaier Genetic Technology Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080806 Termination date: 20160228 |
|
CF01 | Termination of patent right due to non-payment of annual fee |